River Road Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

River Road Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-64,152	Closed	-$3.89M	–	179
2026 Q1	$3.89M	Sell	64,152 -31,655	-33%	-$1.85M	0.04%	164
2025 Q4	$5.17M	Sell	95,807 -3,601	-4%	-$173K	0.06%	160
2025 Q3	$4.48M	Sell	99,408 -883	-0.9%	-$41.2K	0.05%	168
2025 Q2	$4.34M	Sell	100,291 -67,650	-40%	-$3.32M	0.06%	173
2025 Q1	$10.2M	Sell	167,941 -14,543	-8%	-$848K	0.14%	124
2024 Q4	$10.3M	Sell	182,484 -33,839	-16%	-$1.89M	0.14%	119
2024 Q3	$11.2M	Sell	216,323 -4,151	-2%	-$195K	0.15%	118
2024 Q2	$9.16M	Sell	220,474 -62,053	-22%	-$2.78M	0.13%	126
2024 Q1	$15.3M	Sell	282,527 -75,549	-21%	-$3.85M	0.21%	114
2023 Q4	$18.4M	Sell	358,076 -8,526	-2%	-$448K	0.26%	102
2023 Q3	$21.3M	Sell	366,602 -12,752	-3%	-$781K	0.3%	98
2023 Q2	$24.3M	Sell	379,354 -20,718	-5%	-$1.39M	0.33%	89
2023 Q1	$27.7M	Buy	400,072 +16,887	+4%	+$1.19M	0.38%	84
2022 Q4	$27.6M	Sell	383,185 -21,645	-5%	-$1.63M	0.38%	89
2022 Q3	$28.8M	Sell	404,830 -1,485	-0.4%	-$108K	0.43%	80
2022 Q2	$31.3M	Sell	406,315 -6,918	-2%	-$527K	0.44%	73
2022 Q1	$30.2M	Sell	413,233 -854,683	-67%	-$57.4M	0.33%	82
2021 Q4	$79.1M	Sell	1,267,916 -345,538	-21%	-$20.3M	0.84%	44
2021 Q3	$95.5M	Sell	1,613,454 -223,275	-12%	-$14.7M	1.06%	33
2021 Q2	$123M	Sell	1,836,729 -205,935	-10%	-$13.4M	1.32%	22
2021 Q1	$129M	Sell	2,042,664 -51,575	-2%	-$3.21M	1.56%	19
2020 Q4	$130M	Buy	2,094,239 +44,618	+2%	+$2.74M	1.84%	16
2020 Q3	$124M	Buy	2,049,621 +332,859	+19%	+$20M	2.02%	13
2020 Q2	$101M	Buy	1,716,762 +652,857	+61%	+$39M	1.74%	15
2020 Q1	$59.3M	Sell	1,063,905 -48,022	-4%	-$2.94M	1.33%	20
2019 Q4	$71.4M	Buy	1,111,927 +194,210	+21%	+$11.1M	1.13%	26
2019 Q3	$46.5M	Buy	917,717 +177,620	+24%	+$8.35M	0.88%	45
2019 Q2	$33.6M	Sell	740,097 -52,644	-7%	-$2.45M	0.65%	65
2019 Q1	$37.8M	Buy	+792,741	New	+$39.5M	0.84%	53

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

River Road Asset Management's BMY Position: Q2 2026 in Review

River Road Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 64,152 shares — an estimated $3.89M sold.

River Road Asset Management first reported a position in BMY in Q1 2019 and held it in 29 quarters. The position peaked at $130M in Q4 2020. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

River Road Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
River Road Asset Management sold 64,152 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.89M.
River Road Asset Management first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 29 quarters.
River Road Asset Management's Bristol-Myers Squibb position peaked at $130M in Q4 2020.
832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on River Road Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.